Skip to main content
SpringerLink
Log in

Risque moyen ou élevé de cancer colorectal : comment classer en 2014 ? Faut-il changer le paradigme ?

At medium or high risk of colorectal cancer: How should it be classified in 2014? Does the paradigm need changing?

  • Videodigest / /
  • Published:
Acta Endoscopica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. http://www.has-sante.fr/portail/jcms/c_1695396/fr/quand-faut-ilfaire-une-coloscopie-de-controle-apres-une-polypectomie

  2. Hassan C, Quintero E, Dumonceau JM, Regula J, Brandão C, Chaussade S, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013;45:842–51.

    PubMed  Google Scholar 

  3. Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. European Crohn’s and Colitis Organisation. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1–33.

    PubMed  Google Scholar 

  4. Recommandation pour la pratique clinique. Endoscopie digestive basse: indications en dehors du dépistage en population, avril 2004 Service des recommandations professionnelles de l’Anaes. http://www.has-sante.fr/portail/upload/docs/application/pdf/fiche_de_synthese_endoscopie_digestive_2004.pdf

  5. Dépistage et prévention du cancer colorectal. Actualisation du référentiel de pratiques de l’examen périodique de santé (EPS), juin 2013. http://www.has-sante.fr/portail/jcms/c_1623732/en/depistage-et-prevention-du-cancer-colorectal

  6. Winawer S, Fletcher R, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594–642.

    CAS  PubMed  Google Scholar 

  7. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale–Update based on new evidence. Gastroenterology 2003;124:544–60.

    PubMed  Google Scholar 

  8. Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570–95.

    PubMed  Google Scholar 

  9. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000;95:868–77.

    CAS  PubMed  Google Scholar 

  10. Rex D, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. Am J Gastroenterol 2009;104:739–50.

    PubMed  Google Scholar 

  11. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992–3003.

    CAS  PubMed  Google Scholar 

  12. Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM, et al. NCCM guidelines. Version 1.2013; colorectal cancer screening. J Natl Compr Canc Netw 2013;11:1538–75.

    CAS  PubMed  Google Scholar 

  13. Oncology (Williston Park). NCCN Practice guidelines for colorectal cancer. 2000;14:203–12.

    Google Scholar 

  14. Singh MM, Singh E, Miller H, Strum WB, Coyle W. Colorectal cancer screening in women with endometrial cancer: are we following the guidelines? J Gastrointest Canc 2012;43:190–5.

    Google Scholar 

  15. Australian Government, National Health and Medical Research council. Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. https://www.nhmrc.gov.au/guidelines/publications/cp106.

  16. Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006;59:114–24.

    PubMed  Google Scholar 

  17. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006;42:216–27.

    PubMed  Google Scholar 

  18. Wilschut JA, Habbema JD, Ramsey SD, Boer R, Looman CW, van Ballegooijen M. Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a metaanalysis. Cancer Causes Control 2010;21:2287–93.

    PubMed  Google Scholar 

  19. Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med 2012;156:703–9.

    PubMed  Google Scholar 

  20. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992–3003.

    CAS  PubMed  Google Scholar 

  21. Austin GL, Goldstein JI, Peters SL, Ahnen DJ. Are colorectal cancer screening recommendations for first-degree relatives of patients with adenomas too aggressive? Clin Gastroenterol Hepatol 2011;9:308–13.

    PubMed  Google Scholar 

  22. Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 2010;138:877–85.

    PubMed Central  PubMed  Google Scholar 

  23. Tuohy TMF, Rowe KG, Mineau GP, Pimentel R, Burt R, Samadder NJ. Risk of Colorectal Cancer and Adenomas in the Families of Patients With Adenomas A Population-Based Study in Utah. Cancer 2014;120:35–42.

    PubMed  Google Scholar 

  24. Townsend JS, Steele CB, Richardson LC, Stewart SL. Health behaviors and cancer screening among Californians with a family history of cancer. Genet Med 2013;15:212–21.

    PubMed  Google Scholar 

  25. Zlot AI, Silvey K, Newell N, Coates RJ, Leman R. Family history of colorectal cancer: clinicians’ preventive recommendations and patient behavior. Prev Chronic Dis 2012;9:e21.

    Google Scholar 

  26. Mack LA, Cook LS, Temple WJ, Carlson LE, Hilsden RJ, Paolucci EO. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers. Ann Surg Oncol 2009;16:2092–100.

    PubMed  Google Scholar 

  27. Gimeno García AZ, Quintero E, Nicolás Pérez D, Hernández M, Jiménez-Sosa A. Colorectal cancer screening in first-degree relatives of colorectal cancer:participation, knowledge, and barriers against screening. Eur J Gastroenterol Hepatol 2011;23:1165–71.

    PubMed  Google Scholar 

  28. Cottet V, Pariente A, Nalet B, Lafon J, Milan C, Olschwang S, ANGH Group. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 2007;133:1086–92.

    PubMed  Google Scholar 

  29. Delgado-Plasencia L, López-Tomassetti-Fernández E, Hernández-Morales A, Torres-Monzón E, González-Hermoso F. Willingness to undergo colorectal cancer screening in firstdegree relatives of hospitalized patients with colorectal cancer. J Med Screen 2009;16:33–8.

    CAS  PubMed  Google Scholar 

  30. Courtney RJ, Paul CL, Carey ML, Sanson-Fisher RW, Macrae FA, D’Este C, et al. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients. BMC Cancer 2013;13:13.

    PubMed Central  PubMed  Google Scholar 

  31. Ait Ouakrim D, Lockett T, Boussioutas A, Keogh L, Flander LB, Hopper JL, et al. Screening participation predictors for people at familial risk of colorectal cancer: a systematic review. Am J Prev Med 2013;44:496–506.

    PubMed  Google Scholar 

  32. Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009;136:832–41.

    PubMed Central  PubMed  Google Scholar 

  33. Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795–803.

    CAS  PubMed  Google Scholar 

  34. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011;154:22–30.

    PubMed  Google Scholar 

  35. Brenner H, Chang-Claude J, Rickert A, Seiler CM, Hoffmeister M. Risk of colorectal cancer after detection and removal of adenomas at colonoscopy: population-based case-control study. J Clin Oncol 2012;30:2969–76.

    PubMed  Google Scholar 

  36. Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 2014;146:709–17.

    PubMed  Google Scholar 

  37. Lakoff J, Paszat LF, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 2008;6:1117–21.

    PubMed  Google Scholar 

  38. Maruthur NM, Bolen S, Gudzune K, Brancati FL, Clark JM. Body mass index and colon cancer screening: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012;21:737–46.

    PubMed Central  PubMed  Google Scholar 

  39. Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 2013;8:e53916.

    Google Scholar 

  40. Druesne-Pecollo N, Touvier M, Barrandon E, Chan DS, Norat T, Zelek L, et al. Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat 2012;135:647–54.

    PubMed  Google Scholar 

  41. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007;16:2533–47.

    PubMed  Google Scholar 

  42. Matsuo K, Mizoue T, Tanaka K, Tsuji I, Sugawara Y, Sasazuki S, et al. Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan. Ann Oncol 2012;232:479–90.

    Google Scholar 

  43. Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 2010;11:19–30.

    CAS  PubMed  Google Scholar 

  44. Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, et al. Lifestyle factors and colorectal cancer risk: systematic review and meta-analysis of associations with body mass index. Colorectal Dis 2009;11:547–63.

    CAS  PubMed  Google Scholar 

  45. Okabayashi K, Ashrafian H, Hasegawa H, Yoo JH, Patel VM, Harling L, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 2012;107:1175–85.

    PubMed  Google Scholar 

  46. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007;86:556–65.

    CAS  PubMed  Google Scholar 

  47. Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a metaanalysis of cohort studies. World J Gastroenterol 2007;13:4199–206.

    PubMed  Google Scholar 

  48. Omata F, Deshpande GA, Ohde S, Mine T, Fukui T. The association between obesity and colorectal adenoma: systematic review and meta-analysis. Scand J Gastroenterol 2013;482:136–46.

    Google Scholar 

  49. Ben Q, An W, Jiang Y, Zhan X, Du Y, Cai QC, et al. Body mass index increases risk for colorectal adenomas based on metaanalysis. Gastroenterology 2012;142:762–72.

    PubMed  Google Scholar 

  50. Hong S, Cai Q, Chen D, Zhu W, Huang W, Li H. Abdominal obesity and the risk of colorectal adenoma: a meta-analysis of observational studies. Eur J Cancer Prev 2012;21:523–31.

    PubMed  Google Scholar 

  51. Choi Y, Giovannucci E, Lee JE. Glycaemic index and glycaemic load in relation to risk of diabetes-related cancers: a metaanalysis. Br J Nutr 2012;108:1934–47.

    CAS  PubMed  Google Scholar 

  52. Luo W, Cao Y, Liao C, Gao F. Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta-analysis of 24 cohort studies. Colorectal Dis 2012;14:1307–12.

    CAS  PubMed  Google Scholar 

  53. Janghorbani M, Dehghani M, Salehi-Marzijarani M. Systematic review and meta-analysis of insulin therapy and risk of cancer. Horm Cancer 2012;3:137–46.

    CAS  PubMed  Google Scholar 

  54. Sun L, Yu S. Diabetes mellitus is an independent risk factor for colorectal cancer. Dig Dis Sci 2012;57:1586–97.

    PubMed  Google Scholar 

  55. Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 2011;26:863–76.

    PubMed  Google Scholar 

  56. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal, cancer? Am J Gastroenterol 2011;106:1911–21.

    PubMed Central  PubMed  Google Scholar 

  57. Krämer HU, Schöttker B, Raum E, Brenner H. Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences. Eur J Cancer 2012;48:1269–82.

    PubMed  Google Scholar 

  58. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679–87.

    PubMed  Google Scholar 

  59. Noto H, Goto A, Tsujimoto T, Noda M. Cancer risk in diabetic patients treated with metformin: a systematic review and metaanalysis. PLoS One 2012;7:e33411.

    Google Scholar 

  60. Colmers IN, Bowker SL, Tjosvold LA, Johnson JA. Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies. Diabetes Metab 2012;38:485–506.

    CAS  PubMed  Google Scholar 

  61. Colmers IN, Bowker SL, Johnson JA. Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab 2012;38:475–84.

    CAS  PubMed  Google Scholar 

  62. Soranna D, Scotti L, Zambon A, Bosetti C, Grassi G, Catapano A, et al. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist 2012;17:813–22.

    CAS  PubMed Central  PubMed  Google Scholar 

  63. Deng L, Gui Z, Zhao L, Wang J, Shen L. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 2012;57:1576–85.

    CAS  PubMed  Google Scholar 

  64. Zhang ZJ, Zheng ZJ, Kan H, Song Y, Cui W, Zhao G, et al. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care 2011;34:2323–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  65. Hong JL, Meier CR, Sandler RS, Jick SS, Stürmer T. Risk of colorectal cancer after initiation of orlistat: matched cohort study. BMJ 2013;347:f5039.

    Google Scholar 

  66. Kao CH, Sun LM, Chen PC, Lin MC, Liang JA, Muo CH, et al. A population-based cohort study in Taiwan — use of insulin sensitizers can decrease cancer risk in diabetic patients? Ann Oncol 2013;242:523–30.

    Google Scholar 

  67. Chen SW, Tsan YT, Chen JD, Hsieh HI, Lee CH, Lin HH, et al. Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, casecontrol study. Diabetes Care 2013;362:369–75.

    Google Scholar 

  68. Boffetta P, Hazelton WD, Chen Y, Sinha R, Inoue M, Gao YT, et al, Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann Oncol 2012;23:1894–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  69. Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2009;7:682–8.

    PubMed  Google Scholar 

  70. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009;124:2406–15.

    CAS  PubMed  Google Scholar 

  71. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA 2008;300:2765–78.

    CAS  PubMed  Google Scholar 

  72. Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008;1342:388–95.

    Google Scholar 

  73. Heikkilä K, Nyberg ST, Theorell T, Fransson EI, Alfredsson L, Bjorner JB, et al. Work Consortium. Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women. BMJ 2013;346:f165.

    Google Scholar 

  74. Nishihara R, Morikawa T, Kuchiba A, Lochhead P, Yamauchi M, Liao X, et al. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol 2013;178:84–100.

    PubMed Central  PubMed  Google Scholar 

  75. Anderson JC, Moezardalan K, Messina CR, Latreille M, Shaw RD. Smoking and the association of advanced colorectal neoplasia in an asymptomatic average risk population: analysis of exposure and anatomical location in men and women. Dig Dis Sci 2011;56:3616–23.

    PubMed  Google Scholar 

  76. Samadder NJ, Vierkant RA, Tillmans LS, Wang AH, Lynch CF, Anderson KE, et al. Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women. Am J Gastroenterol 2012;107:782–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  77. Shin A, Hong CW, Sohn DK, Chang Kim B, Han KS, Chang HJ, et al. Associations of cigarette smoking and alcohol consumption with advanced or multiple colorectal adenoma risks: a colonoscopy-based case-control study in Korea. Am J Epidemiol 2011;174:552–62.

    PubMed  Google Scholar 

  78. Hong SN, Lee SM, Kim JH, Lee TY, Kim JH, Choe WH, et al. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci 2012;57:2184–94.

    PubMed  Google Scholar 

  79. Zhang Y, Gao C, Zhai JH. Meta-analysis on the relationship between colorectal cancer and Helicobacter pylori infection. Zhonghua Liu Xing Bing Xue Za Zhi 2009;30:73–7.

    CAS  PubMed  Google Scholar 

  80. Zhao YS, Wang F, Chang D, Han B, You DY. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis 2008;23:875–82.

    PubMed  Google Scholar 

  81. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006;112:75–80.

    Google Scholar 

  82. Wu Q, Yang ZP, Xu P, Gao LC, Fan DM. Association between Helicobacter pylori infection and the risk of colorectal neoplasia: a systematic review and meta-analysis. Colorectal Dis 2013;15:e352–64.

    Google Scholar 

  83. Qu X, Jin F, Hao Y, Zhu Z, Li H, Tang T, Dai K. Nonlinear association between magnesium intake and the risk of colorectal cancer. Eur J Gastroenterol Hepatol 2013;25:309–18.

    PubMed  Google Scholar 

  84. Choi Y, Giovannucci E, Lee JE. Glycaemic index and glycaemic load in relation to risk of diabetes-related cancers: a metaanalysis. Br J Nutr 2012;108:1934–47.

    CAS  PubMed  Google Scholar 

  85. Shen XJ, Zhou JD, Dong JY, Ding WQ, Wu JC. Dietary intake of n-3 fatty acids and colorectal cancer risk: a meta-analysis of data from 489 000 individuals. Br J Nutr 2012;108:1550–6.

    CAS  PubMed  Google Scholar 

  86. Wu QJ, Yang Y, Vogtmann E, Wang J, Han LH, Li HL, et al. Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Ann Oncol 2013;24:1079–87.

    CAS  PubMed Central  PubMed  Google Scholar 

  87. Wang ZH, Gao QY, Fang JY. Green tea and incidence of colorectal cancer: evidence from prospective cohort studies. Nutr Cancer 2012;64:1143–52.

    CAS  PubMed  Google Scholar 

  88. Chen GC, Pang Z, Liu QF. Magnesium intake and risk of colorectal cancer: a meta-analysis of prospective studies. Eur J Clin Nutr 2012;66:1182–6.

    CAS  PubMed  Google Scholar 

  89. Wark PA, Lau R, Norat T, Kampman E. Magnesium intake and colorectal tumor risk: a case-control study and meta-analysis. Am J Clin Nutr 2012;96:622–31.

    PubMed  Google Scholar 

  90. Li G, Ma D, Zhang Y, Zheng W, Wang P. Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr 2013;162:346–57.

    Google Scholar 

  91. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman E, et al. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol 2012;23:37–45.

    CAS  PubMed  Google Scholar 

  92. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman E, et al. Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 2011;141:106–18.

    PubMed  Google Scholar 

  93. Kim DH, Smith-Warner SA, Spiegelman D, Yaun SS, Colditz GA, Freudenheim JL, et al. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 2010;21:1919–30.

    PubMed Central  PubMed  Google Scholar 

  94. Liu L, Zhuang W, Wang RQ, Mukherjee R, Xiao SM, Chen Z, et al. Is dietary fat associated with the risk of colorectal cancer? A meta-analysis of 13 prospective cohort studies. Eur J Nutr 2011;50:173–84.

    CAS  PubMed  Google Scholar 

  95. Alexander DD, Miller AJ, Cushing CA, Lowe KA. Processed meat and colorectal cancer: a quantitative review of prospective epidemiologic studies. Eur J Cancer Prev 2010;19:328–41.

    PubMed  Google Scholar 

  96. Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer:a meta-analysis of prospective studies. JAMA 2010;303:1077–83.

    CAS  PubMed  Google Scholar 

  97. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, et al. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 2010;126:1702–15.

    CAS  PubMed  Google Scholar 

  98. Alexander DD, Cushing CA, Lowe KA, Sceurman B, Roberts MA. Meta-analysis of animal fat or animal protein intake and colorectal cancer. Am J Clin Nutr 2009;89:1402–9.

    CAS  PubMed  Google Scholar 

  99. Koushik A, Hunter DJ, Spiegelman D, Beeson WL, van den Brandt PA, Buring JE, et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 2007;99:1471–83.

    PubMed  Google Scholar 

  100. Männistö S, Yaun SS, Hunter DJ, Spiegelman D, Adami HO, Albanes D, et al. Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies. Am J Epidemiol 2007;165:246–55.

    PubMed  Google Scholar 

  101. Bjelakovic G, Nagorni A, Nikolova D, Simonetti RG, Bjelakovic M, Gluud C. Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther 2006;242:281–91.

    Google Scholar 

  102. Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, van den Brandt PA, et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005;294:2849–57.

    CAS  PubMed  Google Scholar 

  103. Xu B, Sun J, Sun Y, Huang L, Tang Y, Yuan Y. No evidence of decreased risk of colorectal adenomas with white meat, poultry, and fish intake: a meta-analysis of observational studies. Ann Epidemiol 2013;23:215–22.

    PubMed  Google Scholar 

  104. Ou Y, Jiang B, Wang X, Ma W, Guo J. Selenium and colorectal adenomas risk: a meta-analysis. Nutr Cancer 2012;64:1153–9.

    CAS  PubMed  Google Scholar 

  105. Zhang X, Albanes D, Beeson WL, van den Brandt PA, Buring JE, Flood A, et al. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst 2010;102:771–83.

    CAS  PubMed Central  PubMed  Google Scholar 

  106. Papaioannou D, Cooper KL, Carroll C, Hind D, Squires H, Tappenden P, et al. Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis. Colorectal Dis 2011;13:1085–99.

    CAS  PubMed  Google Scholar 

  107. Je Y, Liu W, Giovannucci E. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 2009;124:1662–8.

    CAS  PubMed  Google Scholar 

  108. Szilagyi A, Nathwani U, Vinokuroff C, Correa JA, Shrier I. Evaluation of relationships among national colorectal cancer mortality rates,genetic lactase non-persistence status, and per capita yearly milk and milk product consumption. Nutr Cancer. 2006;552:151–6.

    Google Scholar 

  109. Keum N, Aune D, Greenwood DC, Ju W, Giovannucci EL. Calcium intake and colorectal cancer risk: Dose-response metaanalysis of prospective observational studies. Int J Cancer 2014;135:1940–8.

    CAS  PubMed  Google Scholar 

  110. Zhou ZY, Wan XY, Cao JW. Dietary methionine intake and risk of incident colorectal cancer: a meta-analysis of 8 prospective studies involving 431,029 participants. PLoS One 2013;8:e83588.

    Google Scholar 

  111. Pham NM, Mizoue T, Tanaka K, Tsuji I, Tamakoshi A, Matsuo K, et al. Fish consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2013;43:935–41.

    PubMed  Google Scholar 

  112. Wu S, Feng B, Li K, Zhu X, Liang S, Liu X, et al. Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med 2012;125:551–9.

    PubMed  Google Scholar 

  113. Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011;22:1958–72.

    CAS  PubMed  Google Scholar 

  114. Smolinska K, Paluszkiewicz P. Risk of colorectal cancer in relation to frequency and total amount of red meat consumption. Systematic review and meta-analysis. Arch Med Sci 2010;6:605–10.

    Google Scholar 

  115. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 2011;29:3775–82.

    CAS  PubMed  Google Scholar 

  116. Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, Nickel C, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol 2011;35:2–10.

    CAS  PubMed  Google Scholar 

  117. Fife J, Raniga S, Hider PN, Frizelle FA. Folic acid supplementation and colorectal cancer risk: a meta-analysis. Colorectal Dis 2011;13:132–7.

    CAS  PubMed  Google Scholar 

  118. Zhu B, Zou L, Qi L, Zhong R, Miao X. Allium Vegetables and Garlic Supplements do Not Reduce Risk of Colorectal Cancer, Based on Meta-analysis of Prospective Studies. Clin Gastroenterol Hepatol 2014;pii: S1542-3565(14)00451-0.

    Google Scholar 

  119. Liu Y, Tang W, Zhai L, Yang S, Wu J, Xie L, et al. Metaanalysis: eating frequency and risk of colorectal cancer. Tumour Biol 2014;35:3617–25.

    PubMed  Google Scholar 

  120. Yan L, Spitznagel EL, Bosland MC. Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010;19:148–58.

    CAS  PubMed  Google Scholar 

  121. Wang L, Cai S, Teng Z, Zhao X, Chen X, Bai X. Insulin therapy contributes to the increased risk of colorectal cancer in patients: a meta-analysis. Diagn Pathol 2013;8:180.

    PubMed  Google Scholar 

  122. Lytras T, Nikolopoulos G, Bonovas S. Statins and the risk of colorectal cancer: an updated systematic review and metaanalysis of 40 studies. World J Gastroenterol 2014;20:1858–70.

    CAS  PubMed Central  PubMed  Google Scholar 

  123. Liu Y, Tang W, Wang J, Xie L, Li T, He Y, et al. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies. Cancer Causes Control 2014;25:237–49.

    CAS  PubMed  Google Scholar 

  124. Yang G, Hu H, Zeng R, Huang J. Oral bisphosphonates and the risk of colorectal cancer: a meta-analysis. J Clin Gastroenterol 2013;47:741–8.

    CAS  PubMed  Google Scholar 

  125. Bonovas S, Nikolopoulos G, Bagos P. Bisphosphonate use and risk of colorectal cancer: a systematic review and meta-analysis. Br J Clin Pharmacol 2013;76:329–37.

    CAS  PubMed Central  PubMed  Google Scholar 

  126. Ma J, Gao S, Ni X, Chen F, Liu X, Xie H, et al. Exposure to bisphosphonates and risk of colorectal cancer. Br J Clin Pharmacol 2013;76:320–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  127. Singh S, Singh AG, Murad MH, Limburg PJ. Bisphosphonates are associated with reduced risk of colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11:232–9.

    CAS  PubMed  Google Scholar 

  128. Thosani N, Thosani SN, Kumar S, Nugent Z, Jimenez C, Singh H, et al. Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. J Clin Oncol 2013;31:623–30.

    CAS  PubMed  Google Scholar 

  129. Ye X, Fu J, Yang Y, Chen S. Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One 2013;8:e57578.

    Google Scholar 

  130. Bosetti C, Bravi F, Negri E, La VC. Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update 2009;15:489–98.

    PubMed  Google Scholar 

  131. Lin KJ, Cheung WY, Lai JY, Giovannucci EL. The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer 2012;130:419–30.

    CAS  PubMed  Google Scholar 

  132. Ahn JS, Park SM, Eom CS, Kim S, Myung SK. Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies. Korean J Fam Med 2012;33:272–9.

    PubMed Central  PubMed  Google Scholar 

  133. Betés M, Muñoz-Navas MA, Duque JM, Angós R, Macías E, Súbtil JC, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 2003;98:2648–54.

    PubMed  Google Scholar 

  134. Lin OS, Kozarek RA, Schembre DB, Ayub K, Gluck M, Cantone N, et al. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology 2006;131:1011–9.

    PubMed  Google Scholar 

  135. Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med 2007;120:257–63.

    PubMed  Google Scholar 

  136. Ma E, Sasazuki S, Iwasaki M, Sawada N, Inoue M, Shoichiro T, et al. 10-year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010;34:534–41.

    PubMed  Google Scholar 

  137. Yeoh KG, Ho KY, Chiu HM, Zhu F, Ching JY, Wu DC, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011;60:1236–41.

    PubMed  Google Scholar 

  138. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol 2014;12:478–85.

    PubMed  Google Scholar 

  139. Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut 2014;63:1112–9.

    PubMed Central  PubMed  Google Scholar 

  140. Cai QC, Yu ED, Xiao Y, Bai WY, Chen X, He LP, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol 2012;175:584–93.

    PubMed  Google Scholar 

  141. Wong MC, Lam TY, Tsoi KK, Hirai HW, Chan VC, Ching JY, et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut 2013;63:1103–6

    Google Scholar 

  142. Ma GK, Ladabaum U. Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia. Clin Gastroenterol Hepatol. 2014;pii:S1542-3565(14)00240-7.

    Google Scholar 

  143. Sharara AI, Harb AH. Development and Validation of a Scoring System to Identify Individuals at High Risk for Advanced Colorectal Neoplasms Who Should Undergo Colonoscopy Screening. Clin Gastroenterol Hepatol 2014;pii:S1542-3565(14)00595-3.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité d’endoscopie et de consultation digestive, CHG de Redon, F-35600, Redon, France

    D. Heresbach

  2. Clinique du Pont-de-Chaume, 330, avenue Marcel-Unal, F-82017, Montauban, France

    P. Pienkowski

Authors
  1. D. Heresbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Pienkowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Heresbach.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heresbach, D., Pienkowski, P. Risque moyen ou élevé de cancer colorectal : comment classer en 2014 ? Faut-il changer le paradigme ?. Acta Endosc 44, 268–278 (2014). https://doi.org/10.1007/s10190-014-0411-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10190-014-0411-z

Search

Navigation